Records containing: Thyroid Carcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-14Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2026-04-14Drug Use Investigation of Sorafenib/ NEXAVAR® for Unresectable Differentiated Thyroid Carcinoma (DTC)
-
CLINICAL_TRIALS study record update · 2026-04-02Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-23Contrast-enhanced Ultrasound Improves the Diagnostic Performance of Sonographic Risk Stratification System of Thyroid Carcinoma: Comparison Between Integrated Scoring Method and Up-and-down Scoring Method
-
CLINICAL_TRIALS study record update · 2026-03-16Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
-
CLINICAL_TRIALS study record update · 2026-01-22Incidence,Perioperative Risk Factors and Prognosis Associated With Laryngopharyngea Injury After Endotracheal Intubation Under General Anesthesia：A Retrospective Study
-
CLINICAL_TRIALS study record update · 2025-09-22A Clinical Trial of Pembrolizumab (MK-3475) Evaluating Predictive Biomarkers in Subjects With Advanced Solid Tumors (KEYNOTE 158)
-
CLINICAL_TRIALS study record update · 2025-09-19A First-in-Human (FiH) Study of IK-595, an Oral Dual MEK/RAF Inhibitor, in Patients With RAS-or RAF-altered Advanced Solid Tumors
-
CLINICAL_TRIALS study record update · 2025-09-02More Than 50% of the Patients With Clinically Unifocal T1b/Small T2 Node Negative Papillary Thyroid Carcinoma Scheduled for Thyroid Lobectomy May Require Completion Thyroidectomy if the Nodal Status is Evaluated
-
CLINICAL_TRIALS study record update · 2025-07-18The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
-
CLINICAL_TRIALS study record update · 2025-06-18Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study
-
CLINICAL_TRIALS study record update · 2025-04-17Research on the Application of Wrist and Ankle Electrical Stimulation Analgesia Therapy Device in Pain Management After Thyroid Surgery
-
CLINICAL_TRIALS study record update · 2025-03-21Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff
-
CLINICAL_TRIALS study record update · 2025-03-07Evaluation of the Clinical Utility of Circulating Biomarkers in Advanced Thyroid Carcinomas
-
CLINICAL_TRIALS study record update · 2025-02-28A Phase Ib Trial of Vemurafenib Plus Copanlisib to Enhance Radioiodine Avidity in Radioiodine-Refractory Thyroid Cancers
-
CLINICAL_TRIALS study record update · 2025-01-30International Pleuropulmonary Blastoma/DICER1 Registry (for PPB, DICER1 and Associated Conditions)
-
CLINICAL_TRIALS study record update · 2025-01-17Evaluation of Different Diagnostic Therapeutic Strategies in Patients with Thyroid Pathology
-
CLINICAL_TRIALS study record update · 2024-12-12Restoration of Radioiodine Uptake with Selpercatinib in RET Fusion-Positive Radioiodine-Refractory Thyroid Cancer: a Phase 2 Study Performed in Collaboration with the International Thyroid Oncology Group (ITOG)
-
CLINICAL_TRIALS study record update · 2024-08-22Thyroid Cancer and Lymph Node Metastases Detection Using Bevacizumab-IRDye800CW With Molecular Fluorescence Guided Surgery. Thyroid cAncer Surgery With Intraoperative Molecular fluoRescent Imaging to rEduce overtreatmenT and Morbidity
-
CLINICAL_TRIALS study record update · 2024-01-18Effect of Artificial Tears on Radioiodine Levels in the Nasolacrimal Duct System of Patients Following Radioiodine Therapy for Thyroid Carcinoma
-
CLINICAL_TRIALS study record update · 2023-11-29Optimal Dosing of Oral Anticancer Drugs in Older Adults With Cancer: a Randomized Pilot Study.
-
CLINICAL_TRIALS study record update · 2023-04-04European Multicenter Study on Perioperative Management, Operative Strategy, Morbidity, and Outcomes of the Surgical Management of Advanced Thyroid Cancer: (EUROCRINE® Study Group).
-
CLINICAL_TRIALS study record update · 2023-03-08OPTIMISING MOLECULAR RADIONUCLIDE THERAPY: The Role of Quantitative SPECT/CT & PET/CT and Radiation Dosimetry (SELFIE)